MEGGLE Business Unit Excipients is a global leader in the manufacture of lactose for the pharmaceutical industry. Supporting supply chain security with manufacturing facilities in Europe and North America, MEGGLE offers a broad product portfolio of monohydrate, anhydrous and dry powder inhalation (DPI) lactose grades. In order to fulfill special requirements for its customers, MEGGLE offers the development of tailor-made product solutions including individual product specifications (i.e. physical, chemical, microbial parameters). In addition, MEGGLE is a pioneer in co-processing technologies and has developed highly functional excipients possessing unique qualities for directly compressible, immediate & sustained release pharmaceutical solid dosage forms. MEGGLE USA Inc. 592 Route 22, Suite 2B Pawling, NY 12564 T +1 845 289 0264 info.excipients@meggle.com